Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Medicinal Chemicals & Botanical Products

Standard Industrial Classification: SIC 2833

Industry Insider Sentiment Analysis

The Medicinal Chemicals & Botanical Products sector (SIC 2833) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2010-02-05 18:56 2010-01-21 NPHC Nutra Pharma Corporation Rumph Harold Henry Director BUY $0.33 50,000 $16,500 4,350,000
2010-01-13 21:51 2010-01-13 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $31.56 3,500 $110,460 8,064,540
2010-01-13 21:50 2010-01-13 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $31.56 3,500 $110,460 8,064,540
2009-12-29 23:39 2009-12-24 CHBYSM Hero Technologies Inc. HOLLOMAN CORP 10% owner BUY $0.48 1,562,500 $750,000 46,949,091
2009-12-09 23:05 2009-12-09 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $31.20 3,500 $109,200 8,068,040
2009-12-09 23:04 2009-12-09 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $31.20 3,500 $109,200 8,068,040
2009-11-13 21:38 2009-11-11 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $29.34 3,500 $102,690 8,071,540
2009-11-13 21:38 2009-11-11 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $29.34 3,500 $102,690 8,071,540
2009-10-16 18:43 2009-10-14 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $35.62 3,500 $124,670 8,075,040
2009-10-16 18:41 2009-10-14 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $35.62 3,500 $124,670 8,075,040
2009-09-22 21:41 2009-09-03 ESYE Raphael Pharmaceutical Inc. Ofir Guy Director, Officer, 10% owner BUY $0.13 1,404,153 $188,437 21,724,153
2009-09-15 23:28 2009-09-11 USNA USANA HEALTH SCIENCES INC MCCLAIN JERRY G Director OPT+S $30.47 1,000 $30,470 200
2009-09-10 22:51 2009-09-09 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $30.25 3,500 $105,875 8,078,540
2009-09-10 22:50 2009-09-09 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $30.25 3,500 $105,875 8,078,540
2009-09-08 21:15 2009-09-03 HENC Hero Technologies Inc. Macdonald Keith Elliott Director BUY $0.47 50,000 $23,500 237,500
2009-08-25 01:08 2009-08-15 HENC Hero Technologies Inc. Prim Eric C Director, Officer BUY $0.56 10,000 $5,600 646,076
2009-08-21 00:02 2009-07-01 HENC Hero Technologies Inc. Brown James Douglas Director BUY $0.47 30,000 $14,151 3,548,431
2009-08-17 21:09 2009-08-14 USNA USANA HEALTH SCIENCES INC FULLER GILBERT A Director SELL $33.42 3,000 $100,260 3,000
2009-08-14 19:53 2009-08-12 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $31.92 3,500 $111,720 8,082,040
2009-08-14 19:53 2009-08-12 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $31.92 3,500 $111,720 8,082,040
2009-08-06 18:05 2009-08-04 HENC Hero Technologies Inc. Prim Eric C Director BUY $0.52 50,000 $26,150 586,076
2009-08-05 02:16 2009-07-31 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer SELL $34.78 15,000 $521,700 251,209
2009-08-01 00:18 2009-07-30 USNA USANA HEALTH SCIENCES INC Bramble James Officer OPT+S $35.00 1,277 $44,695 0
2009-07-15 19:13 2009-07-15 HENC Hero Technologies Inc. Prim Eric C Director BUY $0.53 50,000 $26,260 536,076
2009-07-14 23:01 2009-07-14 HENC Hero Technologies Inc. Prim Eric C Director BUY $0.49 50,000 $24,520 486,076
2009-06-16 18:08 2009-06-02 HENC Hero Technologies Inc. HOLLOMAN CORP 10% owner BUY $0.10 6,045,218 $604,522 45,386,591
2009-04-15 23:28 2009-04-13 BZI Charlie's Holdings, Inc. GREENBERG SANFORD D 10% owner BUY $0.40 5,500 $2,200 3,152,906
2009-04-14 19:14 2008-03-07 HENC Hero Technologies Inc. Brown James Douglas Director, Officer, 10% owner BUY $0.00 2,460,000 $2,460 2,460,000
2009-04-01 22:53 2009-03-31 MTEX MANNATECH INC SINNOTT ROBERT A Officer BUY $3.37 8,250 $27,803 8,250
2009-03-27 23:35 2008-03-07 HENC Hero Technologies Inc. HOLLOMAN CORP 10% owner BUY $0.00 15,000,000 $15,000 32,237,500
2009-03-27 23:25 2008-12-31 HENC Hero Technologies Inc. HOLLOMAN CORP 10% owner BUY $0.08 1,812,783 $150,461 39,341,373
2009-03-27 23:15 2008-09-30 HENC Hero Technologies Inc. HOLLOMAN CORP 10% owner BUY $0.26 193,050 $50,193 32,430,550
2009-03-20 23:42 2009-03-19 MTEX MANNATECH INC JOBE LARRY A Director BUY $3.50 9,841 $34,444 14,841
2009-03-19 23:52 2009-03-17 MTEX MANNATECH INC WIER PATRICIA A Director BUY $3.23 9,300 $30,014 14,300
2009-03-12 22:57 2008-10-06 HENC Hero Technologies Inc. HOLLOMAN CORP BUY $0.26 5,098,040 $1,300,000 37,335,540
2009-03-05 20:04 2008-10-06 HENC Hero Technologies Inc. Brown James Douglas Director, Officer, 10% owner BUY $0.26 1,078,431 $275,000 3,538,431
2009-02-18 00:58 2009-02-17 BZI Charlie's Holdings, Inc. GREENBERG SANFORD D 10% owner BUY $0.41 8,000 $3,280 3,147,406
2009-02-07 03:54 2009-01-12 CYAN CYANOTECH CORP Yuen Paul Director BUY $1.67 875 $1,461 11,950
2008-12-04 18:59 2008-12-02 EYSE Raphael Pharmaceutical Inc. Ofir Guy Director, Officer, 10% owner BUY $0.06 200,000 $12,500 20,320,000
2008-11-26 01:41 2008-11-04 EYSE Raphael Pharmaceutical Inc. Ofir Guy Director, Officer, 10% owner BUY $0.11 170,000 $18,598 3,589,800
2008-11-26 01:24 2008-10-02 EYSE Raphael Pharmaceutical Inc. Ofir Guy Director, Officer, 10% owner BUY $0.15 39,800 $5,918 3,539,800
2008-11-21 02:16 2008-11-18 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $36.08 7,645 $275,796 8,100,540
2008-11-21 02:16 2008-11-18 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $36.08 7,645 $275,796 8,100,540
2008-11-19 00:58 2008-11-14 USNA USANA HEALTH SCIENCES INC WOOD TIMOTHY E Officer SELL $35.66 7,750 $276,365 27,500
2008-11-14 01:04 2008-11-11 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $35.25 50,000 $1,762,500 8,108,185
2008-11-14 01:05 2008-11-11 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $35.25 50,000 $1,762,500 8,108,185
2008-10-28 01:24 2008-10-06 HENC Hero Technologies Inc. Petersen Grant M Officer BUY $0.26 392,157 $100,000 4,422,157
2008-10-23 18:35 2008-10-06 HENC Hero Technologies Inc. Stevenson Mark E. Director, Officer, 10% owner BUY $0.26 5,294,118 $1,350,000 37,466,322
2008-10-21 23:00 2008-10-17 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer SELL $42.14 9,000 $379,260 320,559
2008-10-20 19:52 2008-10-16 USNA USANA HEALTH SCIENCES INC MCCLAIN JERRY G Director OPT+S $42.36 2,000 $84,720 200
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Medicinal Chemicals & Botanical Products sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2833) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Medicinal Chemicals & Botanical Products

Every transaction in the Medicinal Chemicals & Botanical Products industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.